Press Release: Sanofi in discussions to sell a controlling stake in Opella
Sanofi in discussions to sell a controlling stake in Opella Paris, October 11, 2024. Sanofi today announces that the company...
Month: October 2024
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual...
Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for...
FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival compared with...
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an...
Immatics Announces Pricing of $150 Million Public Offering
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in...
Upstream Bio Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for...
StateHouse Announces Canadian Parent Enters Bankruptcy Proceedings in Canada following Initiation of Receivership Proceedings in the U.S.
SAN DIEGO and TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB:...
CAMP4 Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a...
Kvantify launches physics-based binding affinity-software for drug discovery with high accuracy and unprecedented speed
Koffee binding affinity is the latest addition to Kvantify's computational drug discovery platform, helping the pharmaceutical and biotech industries design...
Waterdrop Inc. Released 2023 ESG Report: Adhere to both Sci-tech Innovation and Social Responsibility
BEIJING, Oct. 11, 2024 /PRNewswire/ -- Waterdrop Inc. released its Environmental, Social and Governance (ESG) Report 2023 ("the Report") in October....
Cantargia Reports New Positive Results on Biomarkers and Safety in CAN10 Phase 1 Clinical Study
LUND, SE / ACCESSWIRE / October 11, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced new...
PMDS’ Largest Shareholder Requests EGM to Appoint New Non-Executive Directors Amid Management Changes
STOCKHOLM, SE / ACCESSWIRE / October 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) 11th October 2024 - PMD Device Solutions...
Cosmo Pharmaceuticals Appoints New Chief Financial Officer
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - October 11, 2024) - Cosmo Pharmaceuticals N.V. (SIX:...
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering
SUNNYVALE, Calif., Oct. 10, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming...
Britannia Launches Financing to Support Britannia Mining Solutions Lab Rollout
Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") today announced...
Exiger Research Identifies 83K Companies Impacted by Hurricane Milton
Most vulnerable sectors include pharmaceuticals, medical devices, agriculture, defense and aerospace WASHINGTON, Oct. 10, 2024 /PRNewswire/ -- Exiger, the market-leading...
Natus seeks FDA 510(k) clearance for its highly anticipated point-of-care EEG solution
MIDDLETON, Wis., Oct. 10, 2024 /PRNewswire/ -- Natus Medical Incorporated announced it has submitted an FDA 510(k) premarket notification to...
Artera Announces Three New Products at Artera Heartbeat Customer Conference
Event Draws 100+ Health Systems for 40+ Sessions Focused on Enhancing the Patient Experience Through Technology and Breaking Down Barriers...
Therapixel Announces Two New FDA Clearances for its Most Advanced Breast Cancer Screening AI Solution
New MammoScreen® AI delivers a comprehensive suite of features including breast density and pre-reporting, creating the ultimate radiologist companion. PARIS...